Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1

Status

Completed 4

Sponsor Class

OTHER 11INDUSTRY 4NETWORK 2NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 2Tumor-Agnostic 1Breast 1

Conditions

Brain Neoplasms 2Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 1023Carboplatin 964Paclitaxel 933Gemcitabine 794Cisplatin 751Docetaxel 683Bevacizumab 609Pemetrexed 502Nivolumab 487Cyclophosphamide 471Capecitabine 461Fluorouracil 418Dexamethasone 403Rituximab 372Oxaliplatin 348Injections 345atezolizumab 298Trastuzumab 298Leucovorin 288Cetuximab 282Irinotecan 268130-nm albumin-bound paclitaxel 254Prednisone 245Doxorubicin 240Ipilimumab 226Lenalidomide 220fludarabine 218Fulvestrant 217durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Gadolinium DTPA × Clear all
NCT00395863 2020-11-05

Multihance at 3 Tesla (3T) in Brain Tumors

Bracco Diagnostics, Inc

Phase 4 Completed
46 enrolled 18 charts
CNS

Brain Neoplasms

NCT01050829 2014-12-30

Gadobutrol Magnevist-controlled Body Study

Bayer

Phase 3 Completed
370 enrolled
Tumor-Agnostic

Neoplasms

NCT00681551 2014-12-15

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis

Bayer

Phase 3 Completed
45 enrolled
CNS

Brain Neoplasms

NCT00486473 2010-07-15

DETECT

Bracco Diagnostics, Inc

Phase 3 Completed
130 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡